December 22, 2023
3 min watch
Save
VIDEO: PHOTON, PULSAR demonstrate effectiveness of Eylea HD
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Michael Stewart, MD, speaks about Eylea HD, the newly approved version of Eylea.
He presents the results of the PULSAR and PHOTON studies, which showed promising results for age-related macular degeneration and diabetic macular edema with long injection intervals.
Editor's note: This article was updated on Jan. 2, 2024, to add the brand name for Eylea HD.
Published by:
Sources/Disclosures
Collapse
Source:
Stewart M, et al. Addressing unmet needs with emerging therapies. Presented at: FLORetina-ICOOR; Nov. 30-Dec. 3, 2023; Rome.
Disclosures:
Stewart reports consulting for Bayer, Biogen and Re-Vana and receiving institutional research support from Alexion.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.